TFF Parmaceuticals (TFFP) PT Lowered to $31 at B.Riley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TFFP Hot Sheet
Price: $0.07 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on TFF Parmaceuticals (NASDAQ: TFFP) to $31.00 (from $36.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Equalweight
- Vitru Brasil Empreendimentos Participacoes (VTRU3:BZ) PT Lowered to R$14.50 at Morgan Stanley
- Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD69.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
